Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?

JOURNAL ARTICLE published December 2008 in Vascular Health and Risk Management

Authors: Mahsa Khoshoi

Update on the clinical use of the low-molecular-weight heparin, parnaparin

JOURNAL ARTICLE published September 2009 in Vascular Health and Risk Management

Authors: Giuseppe Camporese

Combination therapy in cholesterol reduction: focus on ezetimibe and statins

JOURNAL ARTICLE published April 2008 in Vascular Health and Risk Management

Authors: Alberico Catapano

<p>Carotid intima-media thickness among normoglycemia and normotension first-degree relatives of type 2 diabetes mellitus</p>

JOURNAL ARTICLE published May 2019 in Vascular Health and Risk Management

Authors: Dyah Purnamasari | Muhammad Syah Abdaly | Mohamad Syahrir Azizi | Ika Prasetya Wijaya | Pringgodigdo Nugroho

Increased burden and severity of metabolic syndrome and arterial stiffness in treatment na&iuml;ve HIV+&nbsp;patients from Cameroon

JOURNAL ARTICLE published September 2013 in Vascular Health and Risk Management

Authors: William Ngatchou | Daniel Lemogoum | Elisabeth Nga | Michel Hermans

Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes

JOURNAL ARTICLE published January 2015 in Vascular Health and Risk Management

Authors: Thomas Donner | Joshua Joseph

Quick reference guide to apixaban [Corrigendum]

JOURNAL ARTICLE published October 2017 in Vascular Health and Risk Management

Authors: Katherine Hurst | John Matthew O'Callaghan | Ashok Handa

Stress echocardiogaphy: A useful test for assessing cardiac risk in diabetes

JOURNAL ARTICLE published November 2008 in Vascular Health and Risk Management

Authors: RAJAN SHARMA

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey

JOURNAL ARTICLE published January 2014 in Vascular Health and Risk Management

Authors: Robert Petrella | Guy Tremblay | Guy de Backer | Dawn Gill

Corrigendum

JOURNAL ARTICLE published July 2012 in Vascular Health and Risk Management

Authors: Alberto De Caterina

Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein

JOURNAL ARTICLE published September 2008 in Vascular Health and Risk Management

Authors: Pedro Cabrales

Benefits of statin therapy and compliance in high risk cardiovascular patients

JOURNAL ARTICLE published September 2010 in Vascular Health and Risk Management

Authors: Prakash Deedwania

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

JOURNAL ARTICLE published May 2009 in Vascular Health and Risk Management

Authors: Suzanne Oparil

Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease

JOURNAL ARTICLE published December 2014 in Vascular Health and Risk Management

Authors: Peter Toth

Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective

JOURNAL ARTICLE published February 2008 in Vascular Health and Risk Management

Authors: Jayashree Shanker

The use of sibutramine in the management of obesity and related disorders: An update

JOURNAL ARTICLE published May 2009 in Vascular Health and Risk Management

Authors: Themistoklis Tzotzas | Konstantinos Tziomalos | Angela Jones

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

JOURNAL ARTICLE published June 2012 in Vascular Health and Risk Management

Authors: Peter Bramlage | Reinhold Kreutz | Michael Lassen

Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol &ge;70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy

JOURNAL ARTICLE published July 2017 in Vascular Health and Risk Management

Authors: Vybhav Jetty | Charles Glueck | Kevin Lee | Naila Goldenberg | Marloe Prince | Ashwin Kumar | Michael Goldenberg | Ishan Anand | Ping Wang

Olmesartan medoxomil for the treatment of hypertension in children and adolescents

JOURNAL ARTICLE published March 2011 in Vascular Health and Risk Management

Authors: Massimo Volpe

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

JOURNAL ARTICLE published December 2009 in Vascular Health and Risk Management

Authors: J . Dawn Abbott